This website uses cookies to enhance the user experience.
G

GAS 2 FEED AS926 015 605

Research
Limited company
Energivegen 16 4056 TANANGER, Norge

GAS 2 FEED AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
4 years
since Nov 23, 2020
Type
Limited company
VAT registered
Yes
Number of employees
7

Ownership

Number of shares and share classes
24,780
1 share class
Total number of shareholders
4
companies
Belongs to group of

Financials

Total operating income 2023
594,170
NOK
Annual total result 2023
-4,952,670
NOK
Total equity 2023
16,784,174
NOK
Last update: Dec 12, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman
27.78 %
indirectly
Board Member-
Board Member-
Board Member-

Others

NameRoleShares
C
CROWE PARTNER REVISJON AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Chairman
27.78 %
indirectly
-
3.9 %
indirectly
-
1.19 %
indirectly
Last update: Oct 18, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
E
ECOFISHCIRCLE AS
Ordinary shares
12,745
51.43 %
N
NORCE INNOVATION AS
Ordinary shares
8,822
35.6 %
T
TM HOLDING AS
Ordinary shares
3,169
12.79 %
J
JARDIS INVEST AS
Ordinary shares
44
0.18 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 2,650,295
    Operating profit 2023: NOK -6,917,665
    Employees: 6

Financials

in NOK

Summary

Year202320222021
Total operating income
594,170
363,413
182,200
Annual Total Result
-4,952,670
-3,672,317
-2,382,619
Total assets
18,520,040
10,725,760
7,096,911
Total liabilities
1,735,866
2,188,916
888,500
Total equity
16,784,174
8,536,844
6,208,411

P&L

Year202320222021
Total operating income
594,170
363,413
182,200
Total operating costs
5,450,521
3,985,069
2,559,390
Operating result
-4,856,351
-3,621,656
-2,377,190
Financial income/costs
-96,319
-50,661
-5,429
Profit before tax
-4,952,670
-3,672,317
-2,382,619
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-4,952,670
-3,672,317
-2,382,619

Balance overview

Year202320222021
Total fixed assets
9,912,983
3,704,808
2,543,957
Total current assets
8,607,057
7,020,952
4,552,954
Total assets
18,520,040
10,725,760
7,096,911
Short term debt
1,735,866
1,834,516
779,841
Long term debt
0
354,400
108,659
Total liabilities
1,735,866
2,188,916
888,500
Contributed capital
16,784,174
14,600,000
8,599,250
Retained earnings
0
-6,063,156
-2,390,839
Total equity
16,784,174
8,536,844
6,208,411
Total equity and liabilities
18,520,040
10,725,760
7,096,911

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology